SOCIETY FOR NEUROSCIENCE for SOCIETY FOR NEUROSCIENCE
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Education EDU
Communication and outreach concerning the financial impacts of capping facilities and administrative costs to universities and research institutions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALLEN SEGAL | — |
Budget/Appropriations BUD
Advocacy efforts related to FY18 and FY19 funding for National Institutes of Health (NIH) and the National Science Foundation (NSF). Additional advocacy efforts to support completion of FY18 appropriations and raising the budget sequestration caps. Communications to the Office of Management and Budget concerning the President's 2019 budget; stating support for continuing brain research as a top national priority as part of overall federal investment in biomedical research and efforts related to BRAIN Initiative.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALLEN SEGAL | — |
Animals ANI
Communication and outreach concerning the responsible use of animal models in biomedical research. Communication to the Food and Drug Administration (FDA) concerning the closure of the FDA's National Center for Topological Research in Arkansas.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALLEN SEGAL | — |
Medical/Disease Research/Clinical Labs MED
Outreach and communication on the over 1,000 neurological and neurodegenerative diseases that affect nearly 100 million Americans. Communication with NIH over the revised definition of "clinical research" and the impacts on basic science.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ALLEN SEGAL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.